In the ever-evolving pharmaceutical landscape, innovation is a driving force to help manufacturers achieve efficiencies while maintaining safety and regulatory compliance.
For many, their current focus centres on delivering targeted medicines to patients worldwide, with a key component to their development being highly potent active pharmaceutical ingredients (HPAPIs). With the HPAPI market predicted to reach a staggering $34.97 billion by 2028[1], it’s clear that the rising demand for these ingredients necessitates flexible and cost-effective manufacturing solutions that not only streamline processes but also ensure the containment of drug powder materials across pharmaceutical lines.
However, protecting the containment of these drug powders poses challenges to manufacturers, requiring strict adherence to processes and ensuring that cleanrooms have the necessary equipment and capacity for varying batch sizes of drug product transfer.
One solution lies in harnessing single-use technologies (SUTs), with valves and bags offering significant efficiencies when it comes to ensuring uncompromised containment. These technologies not only help to reduce water use, the need for cleaning chemicals and production costs but also protect workers from various health risks associated with exposure to such potent materials.
For a comprehensive guide to perfecting your powder transfer process with the right SUTs, download our recent eBook: Download >
While these innovative technologies offer great potential, choosing an unsuitable SUT can inadvertently exacerbate waste generation and lead to issues that hinder processes and reduce efficiencies.
Below, we examine the critical issues manufacturers must consider when selecting the right SUTs to streamline their powder transfers and minimise risks.
